共 90 条
[1]
Jemal A(2011)Cancer statistics CA Cancer J Clin 61 69-90
[2]
Bray F(2003)Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study J Clin Oncol 21 3194-3200
[3]
Center MM(2004)Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma J Natl Cancer Inst 96 1682-1691
[4]
Ozols RF(2008)Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840 J Clin Oncol 26 1642-1649
[5]
Bundy BN(2009)Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma Gynecol Oncol 114 215-218
[6]
Greer BE(2009)Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial Lancet 374 1331-1338
[7]
Vasey PA(2010)Sequential chemotherapy with carboplatin followed by weekly paclitaxel in advanced ovarian cancer: results of a multicenter phase II study of the northeastern German society of gynecological oncology Gynecol Oncol 116 317-322
[8]
Jayson GC(2004)Phase II trial of trastuzumab followed by weekly paclitaxel/carboplatin as first-line treatment for patients with metastatic breast cancer J Clin Oncol 22 1621-1629
[9]
Gordon A(2001)Weekly and monthly regimens of paclitaxel and carboplatin in the management of advanced ovarian cancer. A preliminary report on side effects Int J Gynecol Cancer 11 295-299
[10]
Seidman AD(2005)A multicenter randomized clinical trial of weekly paclitaxel and carboplatin versus three weeks paclitaxel and carboplatin as first line chemotherapy in epithelial ovarian cancer Zhonghua Yi Xue Za Zhi 85 2099-2103